{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-002314","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.444955+00:00","generated_at":"2026-06-07T01:27:21.396879+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Silo Pharma extends stock repurchase program up to $1M through March 31, 2024","bullets":["Board extended stock repurchase program through March 31, 2024.","Authorization remains at up to $1 million of common stock.","Extension approved on January 9, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-002314","json":"https://secwatch.observer/filing/0001213900-24-002314.json","markdown":"https://secwatch.observer/filing/0001213900-24-002314.md","text":"https://secwatch.observer/filing/0001213900-24-002314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024002314/0001213900-24-002314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024002314/ea191279-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:27:21.396879+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}